1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIQUIDIA CORP
Liquidia Corp XNAS: LQDA

Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

Read More
39.99 1.90 (4.99%)
New 52W High today
2.4M
XNAS Volume

XNAS 14 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Liquidia Corp is scheduled for today, for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
3.8 / 100
Momentum Score
Technically Bullish
77.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
46
1Yr Price target upside is 14%
9 analysts

20

S

12

W

6

O

0

T

SWOT Analysis

Liquidia Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..